Cal International is an online store for promotional items and offers promotional marketing, messaging and specialty advertising solutions.

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Part of ICC Industries, Inc., Pharma Control Corp. is a company headquartered in Englewood Cliffs, NJ, involved in pharmaceutical preparations. On October 06, 1992 ICC Industries, Inc. acquired Pharma Control Corp.

FMC Corporation is an U.S.-based chemical manufacturing company producing chemical solutions for the agricultural, textile, and healthcare industries. The company was founded in California in 1883 when John Bean invented the first piston sprayer for agriculture. FMC Corporation owns superior technology and strong partnerships with customers, and continues to invest in finding solutions that are helping to change people's lives for the better. Today, FMC maintains leading positions in three chemical markets: Agricultural, Specialty, and Industrial. The company uses an array of advanced technologies in research and development, mining and manufacturing to produce customized products and solutions for the many markets they serve. As a global leader utilizing advanced technologies and customer-focused research and development, FMC provides innovative and cost-effective solutions to food and agriculture, pharmaceutical, healthcare, pulp and paper, textiles, glass and ceramics, rubber and plastics, lubricants, structural pest control, turf & ornamental markets, specialty and related industries.

Ranbaxy Laboratories Limited, a pharmaceutical company, produces a range of generic medicines. The company has a presence in 49 countries, manufacturing facilities in 11 countries and serves customers in approximately 125 countries. Products The company manufactures and markets generic pharmaceuticals, value added generic pharmaceuticals, branded generics, active Pharmaceuticals (API) and intermediates. Its product basket of approximately 5,000 SKUs available in approximately 125 countries worldwide, encompasses a therapeutic mix covering a majority of the chronic and acute segments. Research & Development The company offers value added formulations based on its Novel Drug Delivery System (NDDS) and New Chemical Entity (NCE) research outcomes. Novel Drug Delivery Systems (NDDS): The company's NDDS focus is mainly on the development of New Drug Applications (NDA) / Abbreviated New Drug Applications (ANDAs) of oral controlled- release products for the regulated markets. Ranbaxy's in-house NDDS programs are primarily focused on the oral segment. Inhalation (patented devices) and trans-dermal (patented adhesive polymers) programs are also being pursued through collaborations. In the oral NDDS space, Ranbaxy has developed four platform technologies namely Gastro Retentive, Modified Matrix, Multiparticulate and AeroGel. New Drug Discovery Research (NDDR): The company's NDDR program focuses on select therapeutic segments of Infectious diseases, Metabolic diseases, Inflammatory/ Respiratory disease and Oncology. The company has 8-10 programs in the area of NDDR. For Arterolane (potential Anti-malarial candidate), the company has obtained approval from the Drug Controller General of India to initiate Phase III human clinical trials in India. The company is also profiling DPP-IV Inhibitors (Di-Peptidyl Peptidase IV Inhibitors) for Type-2-diabetes, a selective Phosphodiesterase 4-b inhibitor for COPD and Asthma, and a novel antibiotic antibacterial for Community Acquired Respiratory Tract Infection. Under an alliance with an academic institution in India, various medicinal plants are being evaluated as potential sources for novel pharmaceutical agents. The company also has collaborative research projects with other academic institutions in India in the area of Respiratory and Infectious disease. Significant Events In June 2008, Ranbaxy entered into an alliance with Daiichi Sankyo Company Ltd., to create a generic pharmaceutical powerhouse. On September 17, 2009, Ranbaxy Laboratories Ltd. has entered into a strategic in-licensing agreement for the Indian market with Medy-Tox Inc. for its cosmetic product, Neuronox. Neuronox is a botulinum toxin type A complex (100 Units) pharmaceutical manufactured by Medy-Tox. History Ranbaxy Laboratories Limited was founded in 1961.

Johnson & Johnson Consumer, Inc. manufactures health and skin care products. It offers wide variety of lotion, moisturizing cream, baby wash, shampoo and conditioner, baby powder and bath, hand and face wipes, soap, baby oil and cologne. The company was founded on March 8, 2016 and is headquartered in Skillman, NJ.

PMC KK, a subsidiary of CDS Co., Ltd., is a company headquartered in Kawasaki, Japan. The firm plans and produces instruction booklets, service manuals, and catalogues.

Markets pharmaceutical specialties & personal products

Conquer is an enterprise company focusing on high-end chemical drugs for diabetes. The company integrates scientific research, production, and sales, and has gradually developed into a comprehensive innovative enterprise that mainly produces tablets and capsules, and also produces some APIs. Conquer was established in 1999 and is based in Chongqing, China.

Hunan Xinhui Pharmaceutical Co., Ltd., established on 2002-05-27, The business scope includes refined tea,Chinese Herbal Medicine,Primary processing of agricultural products;Chemical raw materials,chemical preparation,biopharmaceuticals,Manufacture of nutritious food;Chinese herbal extract,Chinese patent medicine,Health food production;food,Biological product,Health products,Sales of pharmaceutical raw materials;Acquisition of Chinese herbal medicines,to plant;Chinese patent medicine,Chinese Herbal Medicine,medicine,Wholesale of chemical preparations;Biological product,Plant extracts,Healthy food,food,Chinese medicine,drug development;tablet,hard capsule,Granules,syrup,oral solution(Contains Chinese herbal extracts)production and sales;Agricultural product acquisition;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Sales of products produced by the company(Except for projects prohibited by national laws and regulations;Products involving licensed operation need to obtain a license before they can be operated).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Heilongjiang Fuhe Pharmaceutical Group Co., Ltd., established on 1994-12-28, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Veterinary drug production;Disinfectant production(Free of Hazardous Chemicals);Production of hygiene products and single-use medical products;Production of formula food for special medical purpose;industrial hemp cultivation;industrial hemp flower,leaf,Seed processing;industrial hemp flower,leaf,Seed sales;Drug import and export;Drug Wholesale;Drug retail;Veterinary drug business.General project:Production of Chinese herbal extracts;Disinfectant sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Sales of formula food for special medical purposes;Healthy food(prepackaged)Sales;Import and export;Technology Import and Export.

Changzhou Pharmaceutical Factory (CPF) is a leading pharmaceutical manufacturer of APIs , finished formulations in China. Located in Changzhou, Jiangsu province and has a history of more than half a century. It covers an area of 110,000m2 and employs 900 staffs, including more than 300 technicians with different specialties.

Guangdong Jiu Ming Pharmaceutical Co., Ltd., established on 2001-10-16, Business scope includes licensed projects:pharmaceutical production;Production of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd., established on 2002-07-10, The business scope includes freeze-dried powder injection,powder injection(cephalosporins),powder injection(Penicillins),small volume injection(Contains anti-tumor),eye drops,lotion,Sterile API(mezlocillin sodium,cefpirome sulfate);mezlocillin acid,azlocillinic acid,Ceftezole,ticarcillinic acid,Cefpirome Hydroiodide,2-bromine-(2-chlorine)Methyl phenylacetate,4,5,6,7-Tetrahydrothieno[3,2-C]pyridine,Isoquinoline-5-Production and sales of sulfonyl chloride(licensed production and operation,Production and operation must be licensed);Operating the export business of self-produced products and related technologies of the enterprise and its member enterprises(Except for goods that the state restricts the company to operate or prohibits export);Operate the production of the enterprise and its member enterprises,Raw and auxiliary materials required for scientific research;Equipment,Instrumentation,Import business of spare parts and related technologies.(Except for goods that the state restricts the company to operate or prohibits imports).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Huicheng Ruixiang Pharmaceutical Biotechnology Co., Ltd., established on 2005-06-23, Business scope includes biological,Chemical and pharmaceutical technology development,technical consulting,Technical Services,technology transfer;Medical Research;Health Advisory(Except for medical treatment activities subject to approval);market survey.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policy of the district.)

Beijing Yabao Bio-Pharmaceutical Co., Ltd., established on 2007-06-18, The scope of business includes the production of chemicals,Biological product;technology development,technology transfer,technical consulting,Technical Services;Import and export,Agent import and export,Technology Import and Export;rental factory;Commissioned processing of chemicals,Biological product,food;Technical testing.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Shanxi Tongda Pharmaceutical Co., Ltd., established on 1997-05-30, Business scope includes production and sales of raw materials(Argatroban,Milrinone,Oxiracetam,Lidocaine Hydrochloride,Bisacodyl,Colloidal bismuth pectin,Zinc gluconate,benproperine phosphate,Sulfasalazine,Titanium dioxide,Carrageenate,Apixaban,Moxifloxacin hydrochloride,Paricalcitol,Creatine Phosphate Sodium,Potassium aspartate,iron sucrose,Glucosamine Sulfate)tablet(Hormone,Penicillins,Cephalosporins)hard capsule(Contains penicillins,Cephalosporins)Granules(Contains penicillins,Cephalosporins)Powder,suppositories,tincture,Chinese medicine extraction,oral suspension(dry suspension),Healthy food(Operate with a valid license),Ι class medical device;Car rental;Medical equipment rental;import and export trade;Technology development in the field of medicine,technology transfer,technical consulting,technology R & D,Technical Services;Food production and operation:Food production and sales;Power business:Photovoltaic power generation production and sales of pharmaceutical intermediates(The above can only be operated with a valid license);Business Incubation Services***(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Lepu Hengjiuyuan Pharmaceutical Co., Ltd., established on 2002-06-20, Business range includes tablet(Hormone),hard capsule,Granules,API(Vizyme,Norfloxacin Glutamate,Antazoline Hydrochloride,Daidzein)Production,research and development,Sales;Bioengineering technology development,consult,comminicate,transfer,Promotion service;Health food production,R & D and sales;General Cargo Warehousing Services;Engaged in the import and export of goods and technology(Except for goods and technologies that should be subject to approval before being operated or prohibited for import and export according to national laws and regulations)

Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins; hormone drugs, and other metabolic drugs. The company was founded in June 1951 and is headquartered in Osaka, Japan.

Zensei Pharmaceutical Industries Co., Ltd., part of Nipro Corp., is a Japanese company located in Sakai-shi. The firm manufactures and sells pharmaceuticals.